Skip to main content
. 2010 Jun 11;5(6):e11076. doi: 10.1371/journal.pone.0011076

Figure 1. Response of small cell lung cancer cells to Hsp90 inhibition.

Figure 1

A, MTT assay of H69 cells treated with geldanamycin for 48 h; B, MTT assay of H69 cells treated with radicicol for 48 h; C, MTT assay of H187 small cell lung cancer cells with geldanamycin for 12, 36 and 60 h; D, MTT assay of H889 cells treated with geldanamycin for 48 h; E, MTT assay of U87MG glioblastoma cells treated with geldanamycin for 48 h; F, H69 cells treated with geldanamycin for 48 h and assayed for viable (○) and total (•) cell counts using a Vi-cell XR cell viability analyzer. Error bars show the mean ± SE of three replicates.